The Role of Oxytocin and Sex in Analgesic Placebo-Response: Exploratory Analysis from a Sham Randomized Clinical Trial in Chronic Back-Pain Patients

<b>Background:</b> Several studies suggest that exogenous oxytocin nasal spray may enhance placebo analgesia in healthy volunteers and experimental pain models, although the findings remain mixed. The oxytocin placebo hypothesis suggests that increased oxytocin levels trigger a cascade of brain processes that boost positive expectations and augment the placebo response. Since endogenous oxytocin secretion has been found to increase during positive interactions, we hypothesized that changes in endogenous oxytocin levels will affect placebo analgesia in chronic-back-pain patients. Given the role sex has in both placebo analgesia and oxytocin secretion, we hypothesized that the response magnitude will differ by sex. <b>Methods:</b> Chronic-back-pain patients (<i>n</i> = 112) were prospectively recruited and received placebo injections. The placebo response was calculated as the change in the back-pain Visual Analog Score (VAS), and changes between pre- and post-injection salivary oxytocin levels were measured. The effect of sex and changes in oxytocin levels on pain reduction was calculated using two-way analysis of variance (ANCOVA). <b>Results:</b> Oxytocin levels decreased in 62.5% of participants and increased in 37.5%. Increased oxytocin levels were associated with greater pain reduction than decreased oxytocin levels (<i>p</i> = 0.024). Females exhibited greater pain reduction than males (<i>p</i> = 0.034). No interaction between the oxytocin change pattern and sex was observed. <b>Conclusions:</b> This study demonstrates that following a placebo injection, patients suffering from chronic back pain, who exhibited an increase in endogenous oxytocin levels, showed a higher placebo response. Females had a greater placebo response, but this was not associated with an endogenous oxytocin change. These results provide initial support for the oxytocin placebo hypothesis.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-10-17
DOI
https://doi.org/10.3390/jcm14207348
Citations
1
Primary Topic
Neuroendocrine regulation and behavior
Type
article
Field-Weighted Citation Impact
2.44

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of Oxytocin and Sex in Analgesic Placebo-Response: Exploratory Analysis from a Sham Randomized Clinical Trial in Chronic Back-Pain Patients

Adi Shani, Roi Treister, Nimrod Rahamimov, Mariana Agostinho et al.
1 citations
Journal of Clinical Medicine
Neuroendocrine regulation and behavior
2.44
article

The Role of Oxytocin and Sex in Analgesic Placebo-Response: Exploratory Analysis from a Sham Randomized Clinical Trial in Chronic Back-Pain Patients

Adi Shani, Roi Treister, Nimrod Rahamimov, Mariana Agostinho, Michal Granot, Rinat Mendelson-Keypur, Eilam Paltzur
article en
1 citations

Abstract

<b>Background:</b> Several studies suggest that exogenous oxytocin nasal spray may enhance placebo analgesia in healthy volunteers and experimental pain models, although the findings remain mixed. The oxytocin placebo hypothesis suggests that increased oxytocin levels trigger a cascade of brain processes that boost positive expectations and augment the placebo response. Since endogenous oxytocin secretion has been found to increase during positive interactions, we hypothesized that changes in endogenous oxytocin levels will affect placebo analgesia in chronic-back-pain patients. Given the role sex has in both placebo analgesia and oxytocin secretion, we hypothesized that the response magnitude will differ by sex. <b>Methods:</b> Chronic-back-pain patients (<i>n</i> = 112) were prospectively recruited and received placebo injections. The placebo response was calculated as the change in the back-pain Visual Analog Score (VAS), and changes between pre- and post-injection salivary oxytocin levels were measured. The effect of sex and changes in oxytocin levels on pain reduction was calculated using two-way analysis of variance (ANCOVA). <b>Results:</b> Oxytocin levels decreased in 62.5% of participants and increased in 37.5%. Increased oxytocin levels were associated with greater pain reduction than decreased oxytocin levels (<i>p</i> = 0.024). Females exhibited greater pain reduction than males (<i>p</i> = 0.034). No interaction between the oxytocin change pattern and sex was observed. <b>Conclusions:</b> This study demonstrates that following a placebo injection, patients suffering from chronic back pain, who exhibited an increase in endogenous oxytocin levels, showed a higher placebo response. Females had a greater placebo response, but this was not associated with an endogenous oxytocin change. These results provide initial support for the oxytocin placebo hypothesis.

Journal of Clinical MedicineVol. 14(20)
Bar-Ilan University (IL), Universidade Católica Portuguesa (PT), Western Galilee Hospital (IL), Carmel (Israel) (IL), University of Haifa (IL)
University of Haifa, Fundação para a Ciência e a Tecnologia
Openalex Percentile: Top 9%
Neuroendocrine regulation and behavior
2.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.